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Tremendous progress in the identification, isolation and expansion of stem cells has allowed their application in
regenerative medicine and tissue engineering, and their use as advanced in vitro models. As a result, stem cell
manufacturing increasingly requires scale up, parallelisation and automation. However, solid substrates currently
used for the culture of adherent cells are poorly adapted for such applications, owing to their difficult processing
from cell products, relatively high costs and their typical reliance on difficult to recycle plastics and microplastics.
In this work, we show that bioemulsions formed of microdroplets stabilised by protein nanosheets displaying
strong interfacial mechanics are well-suited for the scale up of adherent stem cells such as mesenchymal stromal
cells (MSCs). We demonstrate that, over multiple passages (up to passage 10), MSCs retain comparable pheno-
types when cultured on such bioemulsions, solid microcarriers (Synthemax II) and classic 2D tissue culture
polystyrene. Phenotyping (cell proliferation, morphometry, flow cytometry and differentiation assays) of MSCs
cultured for multiple passages on these systems indicate that, although stemness is lost at late passages when
cultured on these different substrates, stem cell phenotypes remained comparable between different culture
conditions, at any given passage. Hence our study validates the use of bioemulsions for the long term expansion of
adherent stem cells and paves the way to the design of novel 3D bioreactors based on microdroplet microcarriers.1. Introduction
Since the discovery of mesenchymal stromal cells (MSCs) in bone
marrow in the late 1960s [1,2], MSCs have been isolated from almost
every tissue in the human body [3,4]. MSCs were defined by the Inter-
national Society for Cellular Therapy (ISCT) as a plastic-adherent cell that
maintain self-renewal properties and differentiating potential towards
adipogenic, osteogenic and chondrogenic lineages. MSCs should also
express CD73, CD90 and CD105 whilst remaining negative for CD45,
CD34, CD14 or CD11b, CD79a or CD19 and HLA-DR [5]. Because of their
self-renewal ability and multi-potency, they are one of the most widely
used cell source for clinical applications, whether for cell therapy or
tissue engineering [5–8]. The number of clinical trials registered using
MSCs has steadily increased in recent years [2,4], since their first use in a
clinical trial in 1995 [9]. On-going clinical explorations of the use of
MSCs include treatment for acute graft-versus-host disease (GVHD), bone
and cartilage disease, as well as cardiovascular and myocardial infarctionng, UK.
rot).
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vier Ltd. This is an open access arepair strategies [2,10]. More recent studies also revealed the potential of
MSCs to treat Covid-19 induced pneumonia [11,12]. In most of these
applications, high cell numbers need to be delivered, often in the tens of
millions per treatment. For example, in the case of GVHD treatment,
doses ranging from 0.23 to 9 million cells per kilogram body weight were
used per infusion [13,14]. Since MSCs are relatively sparse and rather
difficult to isolate from patients in large numbers, novel cell
manufacturing platforms are required for the scale up and automation of
processes.
To scale up stem cell manufacturing, several types of bioreactors have
been developed. Amongst these, bioreactors based on microcarriers,
either cultured in conical flasks (similar to bacterial or yeast culture),
stirred tanks or expandable bag systems, have been particularly suc-
cessful [15,16]. Microcarriers, with diameters generally ranging from
100 to 300 μm, can be fabricated from a range of biomaterials such as
dextran, cellulose, polystyrene and polyvinyl acetate [8,17,18]. Owing to
the large surface-to-volume ratio, microcarriers can provide significantlyed 13 November 2021
rticle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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appropriate for the culture of a broad range of anchorage-dependent cells
including MSCs. In addition to their increased volumetric output,
microcarrier cultures are also advantageous to allow cell passaging via
bead-to-bead transfer without enzymatic treatment [8,19]. This not only
saves intensive labour required for cell passaging but also minimises the
risk of contamination. The selection of suitable microcarriers is key to the
success of cell culture scale up as it can impact the growth kinetics and
phenotype of expanded cells [20]. Suitable microcarriers should provide
sufficient anchorage for cell growth, allow the expanded cells to be easily
and efficiently harvested, and should also display adequate physical
mechanical properties to be applied into dynamic systems. The separa-
tion of microcarriers from cell products, especially at larger scales (>L) is
also an important hurdle to their use. Finally, the cost of microcarriers
should be reduced in order to reduce the cost of cell-based therapies and
cell products at industrial scales. Currently, the cost of microcarriers for
the culture of 1 billion cells is in the range of £800–1900, corresponding
to 40–65% of the cost of consumables for cell culture and recovery (based
on calculations made for MSC cultures), the media corresponding to most
of the rest of this cost [18,21]. Several types of commercial microcarriers
have been explored to optimise the culture of MSCs [8,17,18,22,23].
Although quantitative comparison of this data is difficult, those studies
have unanimously highlighted the importance of the surface coating of
microcarriers to promote cell adhesion, proliferation and the retention of
multipotent phenotype. Common ECM protein-coated microcarriers used
for MSC culture include cross-linked dextran-based and denatured
collagen-coated microporous Cytodex 3 and a cross-linked gelatin-based
macroporous CultiSpher-S [18,23–28]. More recently, the adhesion
peptide grafted synthetic polymer-coated polystyrene Synthemax® II
microcarriers have become one of the most frequently used microcarriers
for MSC culture [8,17,28]. For example, Synthemax® II microcarriers
allowed the continuous culture of MSCs for more than 50 days (equiva-
lent to 9 passages) with retention of phenotypic marker expression (CD73
and CD105) and trilineage differentiating potential (adipogenesis,
osteogenesis and chondrogenesis) [28,29]. However, the long term
(multiple passages) benefits of microcarrier-based culture on cell
phenotype and the absence of enzymatic treatment and cell
re-suspension typically associated with culture on traditional 2D plates
have not been systematically quantified.
Overall, important drawbacks that remain in the field of microcarrier
design are the difficulty to process cellular products post culture (i.e.
separating cells from solid microcarriers), often requiring damaging
enzymatic digestion that may impact on cell phenotype and damage to
cell membrane receptors [21]. Moreover, enzymatic digestion might not
be practical on large scale production as the concentration of enzyme and
the incubation times are difficult to control, which would severely impair
cell viability and recovery efficiency [21,30]. The high cost of micro-
carriers also remains a critical issue. Alternative methods avoiding
enzymatic treatments include cell culture on thermoresponsive micro-
carriers (e.g. based on poly(N-isopropyl acrylacmide), PNIPAAm), from
which cells and cell colonies can spontaneously detach by simple
decrease of the temperature below the lower critical solution tempera-
ture (LCST) of PNIPAAm [31,32]. However, this often leads to incom-
plete detachment and still requires separation of suspended cells from
solid microcarriers [25]. Other approaches include the culture of cells on
dissolvable microcarriers which can be easily removed by non-invasive
treatments such as pectinase digestion [21,33], though the micro-
carriers are now discontinued [34]. Overall, in all strategies, additional
processing steps and high costs remain important hurdles to the adoption
of these platforms for the scale up of cell manufacturing. Microplastics
are also increasingly becoming unappealing from an environmental point
of view and their potential contamination of biological products may
pause regulatory hurdles to their long term clinical implementation.
In the last decade, microdroplet microfluidic and flow through2
technologies have revolutionised the field of single cell sequencing, high
throughput monitoring and screening [35,36]. In addition, biphasic
manufacturing platforms such as emulsions are particularly attractive for
the synthesis and purification (e.g. via extraction) of fine chemicals,
therapeutic molecules, polymers and nanomaterials, and are widely
applied in chemical engineering and manufacturing. However, the
implementation of microdroplet platforms for adherent cell culture and
stem cell technologies has remained limited, as thought to be incom-
patible with the importance of substrate mechanics in regulating cell
adhesion and stem cell phenotype [37,38].
Cell adhesion to biomaterials, mediated by integrin binding to extra-
cellular matrix proteins and ligands, is indeed regulated by matrix
mechancis [39–41]. In turn, this process regulates the actomyosin cyto-
skeleton assembly and contractility and a wide range of phenotypes, via
mechanisms such as ERK, SMAD, MAL/SRF and YAP signalling [40,42,
43]. At first glance, cell adhesion to liquids (e.g. oils) is therefore unex-
pected. However, in the 1980s, Keese and Giaever reported that some
liquids enabled the adhesion and proliferation of fibroblasts and that this
phenomenon required supplementation with surfactant molecules [44,
45]. The precise mechanism enabling this process remained unclear.
More recently we reported that cell adhesion to low viscosity liquids,
including fluorinated and silicone oils was dependant on the
self-assembly of strong protein nanosheets at corresponding liquid-liquid
interfaces [46–48]. We demonstrated that co-surfactant molecules such
as pentafluorobenzoyl chloride (PFBC) modulate the interfacial me-
chanics of protein nanosheets, in turn regulating cell adhesion via the
classic integrin-mediated actomyosin machinery [47,48]. This allowed
the culture of a broad range of cell types, including human primary
keratinocytes and MSCs [46–48], fibroblasts [44,45,49,50] and myo-
blasts [51,52]. In some cases, ECM proteins were found to directly
assemble at the surface of some liquids and promote cell adhesion and
culture on 2D liquid interfaces [53], but this remains difficult to control
and does not support the stabilisation of associated emulsions for appli-
cation in 3D bioreactors. Therefore protein nanosheet technologies
appear attractive to mediate ECM protein and ligand functionalisation
whilst controlling interfacial mechanics and emulsion stability. Although
the proof of concept of these systems and the simplification of cell pro-
cessing (e.g. via centrifugation) have been demonstrated, the long term
expansion of stem cells on bioemulsions and the characterisation of their
phenotype has not been established yet.
In this work, we generate bioemulsions stabilised by poly(L-lysine)
nanosheets, co-assembled with the surfactant PFBC and systematically
characterise the long term expansion of MSCs at their surface. These
nanosheets were selected based on a previous study in which we reported
the ability to support cell adhesion to liquid interfaces and studied some
of the parameters regulating their self-assembly [48]. We present the first
side-by-side comparison of the performance of bioemulsion microcarriers
with solid microcarriers (commercial Synthemax® II) and 2D tissue
culture flasks for the long term (multiple passages) expansion of MSCs
(Fig. 1). We characterise the morphology of cells produced at different
passages, their overall expansion and expression of stem cell markers via
PCR and flow cytometry. We characterise the retention of multi-potent
phenotypes after different culture periods by inducing differentiation
into osteo-, adipo- and chondrogenic lineages and characterising the
phenotype of resulting cells. Overall, our results demonstrate that MSC
phenotypes after long term expansion on bioemulsions, solid micro-
carriers and 2D culture flasks are comparable. We observe that the stage
of cell expansion (passage number) has a far more important impact on
MSC phenotype than any difference between the 3 culture platforms
studied, at any given time. Therefore, our study demonstrates the feasi-
bility of protein nanosheet-stabilised bioemulsions for the long term
expansion of stem cells and their application in 3D bioreactors for the
production of stem cells with preserved phenotype.
Fig. 1. Protein nanosheets self-assembled at liquid-liquid interfaces allow the stabilisation of bioemulsions. Their strong interfacial mechanical properties allow the
resulting interfaces to resist cell-mediated contractile forces and regulate cell spreading. Following expansion for multiple passages, cells are harvested (via centri-
fugation) and their stem cell phenotype is characterised via morphometry, flow cytometry and cell differentiation assays.
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2.1. Generation of protein nanosheet-stabilised bioemulsions
1 mL fluorinated oil (Novec 7500, ACOTA) containing the fluorinated
surfactant 2,3,4,5,6-Pentafluorobenzoyl chloride (PFBC, Sigma-Aldrich)
at a final concentration of 10 μg/mL and 2 mL of poly(L-lysine) (PLL)
solution (200 μg/mL, Sigma-Aldrich) in PBS (pH adjusted to 10.5) were
added in a 15 mL centrifuge tube. The tube was vigorously shaken via
vortexing for 15 s, to mix both phases and generate the emulsion and
subsequently left to incubate at room temperature for 1 h. The top liquid
phase, above the settled emulsion was aspirated and replaced with PBS 6
times. Human plasma fibronectin (FN, Sigma-Aldrich) was deposited at
the surface of oil droplets after PLL adsorption. 20 μL of FN (1 mg/mL)
was added (final concentration of 10 μg/mL) and incubated at room
temperature for 1 h. The top liquid phase above the bioemulsion was
aspirated and replaced with PBS 6 times. For cell seeding, 500 μL of
growth medium were added in a 24 well plate treated with 300 μL
poly(L-lysine)-graft-polyethylene glycol (PLL-g-PEG, SuSoS AG, 25 μg/
mL) for an hour and washed with PBS three times. 120 μL of the bio-
emulsion was then transferred to each well before 500 μL of growth
medium containing MSCs at the desired density was added.
To characterise the bioemulsion surface area, bioemulsions were
imaged via bright field microscopy. Images were analysed by outlining
microdroplets via imageJ using the TrainableWeka Segmentation plugin,
allowing the measurement of their diameter and surface area. For fluo-
rescence imaging, Alex Fluor 594-conjugated PLL was used. The conju-
gated PLL stock solution was prepared by dissolving PLL powder in 0.1 M
NaHCO3 buffer and reacting with Alexa Fluor 594 NHS ester (succini-
midyl ester, Sigma-Aldrich) dissolved in DMSO. The conjugated PLL was
mixed with non-labelled PLL at 1:9 ratio and added into each well to a
100 μg/mL final concentration. The incubation and washing process was
the same as the one described above.2.2. Mesenchymal stromal cell (MSC) culture, cryopreservation and
thawing
Bone marrow derived human MSCs were obtained from PromoCell
and cultured from passage 2 on T75 flasks in MSC growth medium
(PromoCell) in an incubator (37 C and 5% CO2). Medium changed every
other day. When 70–80% confluency was reached, MSCs were harvested3
with 4 mL Accutase solution (PromoCell), centrifuged, counted and
resuspended in freezing medium (Cryo-SFM, PromoCell) at the 500,000/
mL. 1 mL of cell suspension was transferred to each cryovial and stored in
a Mr. Frosty™ freezing container. The container was kept at 80 C for
24 h before transferring the vials to a cell bank filled with liquid nitrogen.
The same batch of cells was not cryopreserved more than once. For long-
term culture experiments, MSCs were thawed at passage 3 on T75 flasks
in the growth medium. When the confluency was reached, the cells were
harvested for real-time PCR (RT-PCR), flow cytometry, as well as seeded
to the corresponding substrates at 20,000 cells per well to start long-term
expansion experiments.2.3. Long-term MSC culture, passaging and harvesting on microcarriers
To avoid cell adhesion to tissue culture plastic (TPS) and restrict cell
adhesion to bioemulsions or solid microcarriers, 300 μL of 25 μg/mL PLL-
g-PEG solution were used to coat each well of a 24-well plate and left to
incubate for 1 h. The PLL-g-PEG solutions were then aspirated and wells
were washed with PBS twice before 500 μL growth medium was added
into each well. 120 μL of bioemulsion (or 20 mg of Synthemax® II
microcarriers pre-incubated with 500 μL MSC growth medium) were
then transferred to each well, allowing the microcarrier suspension to
fully cover of the surface of the well. MSCs were then gently seeded at a
density of 20,000 cells/well and placed in an incubator without shaking
for 24 h. Hence the densities of MSCs seeded per cell adhesive area were
2,100, 4200 and 2800 cells/cm2, for TPS, Synthemax® II and bio-
emulsions, respectively. We note that such rest period, or alternative
methodologies, could be optimised to improve cell seeding efficiency,
but this was not further studied in this work. The well-plate was then
placed on an orbital shaker (VWR) and agitated at a speed of 70 rpm, in
an incubator (37 C and 5% CO2). When 70–80% cell confluence was
reached, cell passaging on emulsions and mirocarriers was carried out by
transferring 1/3 of the bioemulsion/microcarrier suspension to a new
well (coated with PLL-g-PEG) containing fresh bioemulsion/micro-
carriers with medium. This allowed cell migration from droplet-to-
droplet (or microcarrier-to-microcarrier) without requiring the use of
enzymatic treatment and cell detachment. The well-plate was placed on
an orbital shaker (VWR, Stuart™ Gyratory rocker, SSL3) and agitated at a
speed of 40 rpm, in an incubator (37 C and 5% CO2). After 24 h, the
speed was increased to 70 rpm.
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by pipetting to a centrifuge tube, the residual excess medium was
removed before the emulsion was washed with PBS three times. The tube
was then centrifuged for 5 min at a speed of 1500 rpm to break the
bioemulsion. The cell pellets were collected at the interface between the
PBS and oil phases. For cells cultured on microcarriers, the microcarriers
were transferred in a centrifuge tube by pipetting. When the micro-
carriers were settled at the bottom of the tube, the medium was removed
before the PBS was added into the tube to wash off excess medium. The
microcarriers were incubated with Accutase solution for 5 min in an
incubator for cell detachment. The solution was transferred to another
centrifuge tube cappedwith a cell strainer to separate detached cells from
the microcarriers. The flow through was saved and the cell pellet was
collected after 5 min centrifugation at a speed of 1200 rpm.
2.4. DNA quantification for characterisation of cell proliferation
Cell densities were determined via DNA quantification using
CyQUANT™. Cells cultured from corresponding substrates (TPS/bio-
emulsion/microcarriers) were collected at desired time points (as indi-
cated above), transferred into a 2 mL microcentrifuge tube and washed
with PBS three times before storage at 70 C, to induce cell lysis.
Resulting suspensions were thawed at room temperature and incubated
with CyQUANT™ kit solutions, following protocols outlined by the
manufacturer. The resulting solution was then transferred into a 96-well
plate and the fluorescence intensity was quantified using a fluorescence
microplate reader set up with excitation at 480 nm and emission at 520
nm. To convert absorbances into cell densities, standard curves generated
from known cell densities (but recovered from TPS and bioemulsion/
microcarriers using identical protocols to those used for each system; to
account for the impact different substrate may have on recovery and DNA
quantification, three separate calibration curves were generated) were
generated (see Supplementary Fig. S1). The population doubling time
was calculated as (t2-t1)/(3.32*(log(N2)-Iog(N1))), where t1 and t2 are the
start and end time points of the experiments, respectively, and N1 and N2
are the cell densities at the start and end time points, respectively,
measured via the CyQUANT™ assay.
2.5. Immunostaining and fluorescence imaging
Cell adhesion was studied via immunostaining of adherent cells
(vinculin and phalloidin). Cells were harvested from different substrates
as described above and reseeded (5000 cells/well, 500 μLMSC expansion
medium) on glass coverslips pre-coated with FN in 24-well plates. After
24 h, the samples were washed with PBS and fixed with 500 μL 4% PFA
for 10 min, washed with PBS, before permeabilization with 500 μL 0.4%
Triton X-100 solution (in PBS) for 5 min at room temperature. This was
followed by 1 h blocking (PBS containing 3 wt% BSA), with simultaneous
staining for actin by introducing tetramethyl rhodamine isothiocyanate
phalloidin in the bocking solution (Sigma-Aldrich, 1:1000). Samples
were subsequently incubated with the corresponding primary antibody
(Sigma-Aldrich, mouse anti-vinculin, 1:400 in blocking buffer) for 1 h at
room temperature, washed with PBS and then incubated with Alexa
Fluor 488-conjugated secondary antibody (Sigma-Aldrich, goat-anti-
mouse 1:1000 in blocking buffer) and Dapi (Sigma-Aldrich, 1:1000 in
blocking buffer) for 1 h at room temperature. After washing in PBS and
deionised water, stained samples were mounted in Mowiol on coverslips
and imaged using a Leica DMI4000B epifluorescence microscope. To
quantify cell spreading and morphology, cytoskeleton images were
analysed using thresholding and watershedding protocols in ImageJ.
Focal adhesions were analysed by ImageJ using a previously reported
protocol.59 Focal adhesion sized between 0.5 and 10 μm2 were consid-
ered for this analysis.4
2.6. Live imaging
Live imaging of cells migrating from one microdroplet to another or
from droplets to solid stubstrates was performed to examine their ability
to be directly transferred without enzymatic digestion. For droplet to
droplet transfer, bioemulsions at the surface of which confluent cells
(MSCs) had been allowed to grow were transferred to a new well con-
taining freshly prepared microdroplets (PLL and fibronectin coated as
above), in growth medium. For droplet to solid transfer, bioemulsions at
the surface of which confluent cells (MSCs) had been allowed to grow
were transferred to a new well (non-coated with PLL-g-PEG) in growth
medium. A Lumascope 720 microscope was used to image wells every 15
min over a period of 20 h (the video is run at 15 frames per second).2.7. MSC differentiation and phenotypic characterization
MSCs were cultured at a density of 50,000 cells per well in 48-well
plates. After 24–72 h incubation, when 100% confluency was reached,
differentiation was induced by replacing the growth medium with either
osteogenic differentiation or adipogenic differentiation medium (Pro-
moCell), whilst control groups were kept in culture in growth medium.
The media were replaced every three-days over a period of two weeks.
For chondrogenesis, cells were seeded in U-bottom 96-well plates
(Greiner Bio-One) for 72 h to allow the formation of spheroids. Chon-
drogenesis was induced by culturing in chondrogenic differentiation
medium (PromoCell) while the undifferentiated control group was
cultured with Dulbecco's Modified Eagle's Medium (DMEM, low glucose,
Sigma-Aldrich) with 2 mM L-glutamine and 10% FBS (PAA). The media
were replaced three times a week for a period of three weeks.
2.7.1. Oil red staining
Oil Red solutions allow to stain (red-orange) lipid droplets produced
during adipogenesis. Oil Red staining stock solutions were prepared by
dissolving 150 mg of Oil Red O powder (Sigma-Aldrich) with 50 mL of
99% isopropanol. The solution was filtered and stored in the dark after
the powder was fully dissolved. The working solution was prepared by
mixing the Oil Red stock solution with DI water at 3:2 ratio for 10 min,
the mixture was then filtered via a 0.2 μm filter. Samples were washed
twice with PBS before being fixed with 4% PFA for 10 min. After which,
the samples were washed three times with PBS to remove excess PFA and
then stained with the Oil Red working solutions. After incubation for 1 h,
samples were washed six times with PBS and imaged by bright field
microscopy.
2.7.2. Alkaline phosphatase (ALP) staining
Solutions were prepared by dissolving one 5-bromo-4-chloro-3-
indolyl phosphate/nitro blue tetrazolium tablet (BCIP/NBT, Sigma-
Aldrich) in 10 mL DI water. Samples were washed with 0.1 M PBS
three times and then fixed in 90% ice cold ethanol for 4 min. After
washing three times with DI water, BCIP/NBT working solutions were
added to each sample and incubated for 1 h at room temperature. After
incubation, samples were washed three times with DI water and imaged
by bright field microscopy.
2.7.3. Alizarin Red staining
Alizarin Red solutions were prepared by dissolving 1 g Alizarin Red S
powder (Sigma-Aldrich) in 50 mL DI water. After the pH of the solution
was adjusted just below 4.2 with hydrochloric acid, the solution was
filtered using a 0.2 μm filter and stored in the dark. Samples were washed
twice with PBS and fixed with 4% PFA for 10 min. Samples were washed
three times with DI water, then incubated with the Alizarin Red working
solution. After 1 h incubation, samples were washed six times with DI
water and imaged by bright field microscopy.
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Working Alcian Blue staining solutions were prepared by dissolving
10 mg Alcian Blue 8 GX (Sigma-Aldrich) in solutions of 6 mL ethanol and
4 mL acetic acid. A de-staining washing solution was prepared by mixing
12 mL ethanol with 8 mL acetic acid. After washing twice with PBS to
remove excess medium, the spheroid was fixed with 4% PFA for 45 min
at room temperature. After rinsing with PBS three times, the sample was
left in the Alcian Blue working staining solution overnight. The staining
solution was carefully removed and the spheroid was washed three times
with the destaining solution for 10 min, prior to taking images with a
camera.
2.8. Flow cytometry
For flow cytometry, the antibody panels were designed as CD105-
FITC, CD73-RPE and CD-90-APC or CD105-RPE, CD73-FITC and CD90-
APC for positive panels, CD34-FITC, CD45-RPE and CD19-Pacific Blue
for negative panels (Bio-Rad). Unstained controls, single colour controls
and fluorescence minus one control (FMO, samples are stained for all the
flurochromes in the panel, except for one) were also performed respec-
tively for voltage adjustment, compensation and positive gating. All the
antibodies were prepared in PBS containing 1% BSA at dilutions sug-
gested by the supplier. After culture on TPS, bioemulsions or solid
microcarriers at passage 4, 6, 8 and 10 (from cells at passage 3), MSCs
were harvested by accutase solution treatment, as single cell suspensions,
from the corresponding substrates and transferred to 2 mL micro-
centrifuge tubes at a density of 1  106 cells/tube. Cells from each sub-
strate were individually stained with one of the panels, at a volume of
100 μL for 30 min on ice. After washing with 1.5 mL PBS, each micro-
centrifuge tube was filled with 300 μL ice cold PBS. Flow cytometry was
performed on a FACS Canto II instrument (BD Biosciences). 405 Coherent
VioFlame, 488 Coherent Sapphire and 635 JDS Uniphase HeNe lasers
were used for excitation and sorting. The results were analysed by
Flowjo. For data analysis, gating was performed to discard dead cells,
debris and cell doublets before CD73 positive cells were selected on
histograms first (CD73 is highly expressed thus can be easily discrimi-
nated from negative signals in histograms), based on the FMO control.
Cells co-expressing CD105 and CD90 were then sub-gated from the dot
plot, based on the corresponding FMO control.
2.9. Real-time polymerase chain reaction (RT-PCR)
The RNA of MSCs (harvested after culture at the desired time point,
on the substrate of interest) was extracted via a Qiagen RNeasy Kit ac-
cording to the protocol from the supplier. The concentration of extracted
RNA was measured via Nanodrop (Thermo Fisher) and the RNAwas then
reverse-transcribed using QuantiTect® Reverse Transcription Kit (Qia-
gen) following the protocol from the supplier. The cDNA obtained was
preserved at 20 C. RT-PCR experiments were set up and performed
following the Taqman® Gene Expression Assay protocol using the kit in a
QuantStudio™ Real-Time PCR System (Applied Biosystems™). Beta-2-
microglobulin (B2M, Hs00187842_m1, Thermo Fisher) was selected as
the housekeeping gene, and results were shown as the relative value
obtained, comparing all samples to newly thawed P3 cells controls. Since
some of the differentiation markers did not express under growth me-
dium condition, the P4 cells cultured on TPS in differentiation medium
were used as controls for differentiation. Analysis of the results was
performed according to 2ΔΔCt method. Details of target genes are pre-
sented in the Supplementary Table S1.
2.10. Statistical analysis
Statistical analysis was carried out using Origin 2019 through one-
way ANOVA with Tukey test for posthoc analysis. Significance was
determined as * P < 0.05, **P < 0.01, ***P < 0.001 and n.s., non-
significant. Throughout the manuscript, SD abbreviates standard5
deviation. S.E. abbreviates standard error.
3. Results and discussion
The selection of protein nanosheets for the stabilisation of bio-
emulsions supporting MSC adhesion and expansion was based on several
key criteria: 1. The formation of mechanically strong protein nanosheets
able to resist cell-mediated contractile forces generated during cell
spreading and migration; 2. The ability to readily adsorb ECM proteins at
the surface of resulting protein nanosheets; 3. The stabilisation of oil
microdroplets resulting in bioemulsions that persist during cell culture.
We previously identified two types of protein nanosheets displaying
strong interfacial mechanics and supporting cell adhesion and expansion
[47,48]. Albumin nanosheets assemble fast in physiological conditions,
with ultimate interfacial moduli in the range of 10–40 mN/m [47].
Poly(L-lysine) (PLL) nanosheets form stiffer interfaces (interfacial moduli
near 3 N/m), but also enable rapid fibronectin adsorption owing to their
positive charge [48]. Although cell adhesion to liquids has also been
reported through simple adsorption from medium proteins (often intro-
duced via the serum used) and direct fibronectin adsorption, we did not
select these systems as we found that the former was not supporting MSC
adhesion (especially on emulsions displaying high surface curvature),
whereas the latter did not promote the formation of stable emulsions and
was reported to be very dependent on oil type. However, the stability of
PLL nanosheet stabilised bioemulsions in culture conditions had not been
investigated. The fluorinated oil Novec 7500 was selected owing to its
high density, cytocompatibility and use in biotechnology applications
and microdroplet microfluidic systems [54].
Therefore, we first investigated the long-term stability of PLL-
stabilised bioemulsions in culture conditions, including the impact of
high cell densities on microdroplet stability over a period of 7 days. Over
this time period, we observed no apparent flocculation of emulsions or
phase separation. Emulsions maintained a spherical shape without sig-
nificant distortion (Fig. 2A). This was confirmed by analysing the size
distribution of emulsions in the absence and presence of cells (Fig. 2B).
Histograms indicate a slight broadening of the emulsion size distribution,
although the average diameter only increased from 149 to 171 μm. The
average volume of droplets was found to increase after cell seeding and
increased slightly at later time points (Supplementary Fig. S2), but
without macroscopic phase separation of the bioemulsions, whether with
or without cell seeding. This could be associated to some level to the
destabilisation of some of the droplets in the system, but also perhaps
with a slight deformation of the droplets after 5–7 days of culture
(perhaps as a result of cell-mediated forces).
To investigate whether cells are able to migrate from one bioemulsion
droplet to another, thus enabling to bypass cell detachment for passaging,
we introduced freshly prepared bioemulsions generated with tagged PLL
(Alexa Fluor 594) together with bioemulsions on which MSCs had been
cultured for 7 days and reached confluency. 3 days following the intro-
duction of this new bioemulsion, MSCs could be seen to migrate to the
new carriers and to populate these new surfaces (Fig. 3). This process was
also confirmed via live imaging over a period of 5 h (Supplementary
Video S1), during which cells bridged the gap between droplets and
gradually migrated to fresh carriers. Similarly, MSCs were found to
migrate from microdroplets to the underlying substrate, following
droplet transfer to cell-adherent wells (Fig. 3D and Supplementary Video
S2). We note that other methodologies could be developed to promote
faster migration/adhesion to new microcarriers, such as cell collection
after centrifugation/detachment and reseeding. We also note that
quantification of the number of microcarriers covered by cell colonies
may allow identifying some of the factors limiting expansion on micro-
carriers and would be an aspect deserving attention. However, this step
was not further optimised in our study.
Supplementary data related to this article can be found at https://
doi.org/10.1016/j.mtbio.2021.100159.
For long term expansion studies (equivalent to 6 cycles of expansion/
Fig. 2. The stability of PLL/FN bioemulsions is maintained in the presence of MSCs over a period of 7 days. A) Bright field microscopy images of bioemulsions with
and without MSCs over a period of one week (under agitation) and B) corresponding histograms of size distributions and average radii  SD.
L. Peng, J.E. Gautrot Materials Today Bio 12 (2021) 100159passaging), we compared MSCs cultured on bioemulsions to cultures on
the solid microcarriers Synthemax® II as well as conventional culture on
2D tissue culture polystyrene (TPS, 6 well plate). The volumes of bio-
emulsions and weight of microcarriers introduced in each well of a 24
well plate (with surface passivation with PLL-PEG to prevent cell adhe-
sion to the plastic) corresponded to surface areas of 4.8 and 7.2 cm2
(compared to 9.6 cm2 for the surface of a well in a 6-well plate for TPS),
respectively, with cell densities per well (20,000 cells) and volume of
medium (1.5 mL) kept constant in all three conditions. Cell densities at
different time points and passage times were evaluated via DNA quan-
tification assay (CyQUANT™ assay, Fig. 4; data compared to our stan-
dard, Supplementary Fig. S1). At early time points (day 1), we found no
difference in cell densities in the different culture systems, suggesting
comparable levels of seeding efficiencies (although some impact of
cycling cannot be ruled out). After 5 days of culture, cells proliferated in
all conditions and were found to cover the surface of microcarriers. Cell
densities were found to be comparable in microcarriers (solid or liquid)
and were slightly higher than those observed on TPS (p<0.05). Similar
trends were observed in subsequent passages (Supplementary Fig. S3).
We do note a slight increase in the population doubling time observed on
bioemulsions at P6 and P8. However, at passage 10, there was an
apparent decrease in cell cycling observed on all substrates, with overall
reduced cell densities, consistent with a reduction in cell proliferation
reported in the literature [55–57]. This was particularly pronounced in
the case of cells cultured on solid microcarriers, for which we measured a
particularly strong increase in passage doubling time (Supplementary6
Fig. S4). Therefore, our results indicate the excellent proliferation po-
tential of MSCs cultured on bioemulsions (comparable to that observed
on solid microcarriers) and the overall cell cycling performance that can
be achieved on bioemulsions in 3D platforms.
The phenotype of MSCs cultured over prolonged passage times was
next examined. Cell spreading and morphology is considered as one
important hallmark of the MSC phenotype, and differentiation has been
associated with changes in focal adhesion formation and actin reorgan-
isation [58]. Therefore, we quantified the morphology of MSCs cultured
at different passages on the three substrates studied. To do so, as cells
respond to the biochemistry and mechanics of their microenvironment,
MSCs were reseeded on identical fibronectin coated glass substrates
allowing direct comparison of morphologies. Cell spreading gradually
increased with passage number (in particular at passage 10, Fig. 5),
possibly indicating a shift towards osteogenic differentiation or cell
senescence [59,60]. No significant difference was observed between cell
spreading or morphology for MSCs cultured on the different substrates
studied, throughout the culture period when comparisons were made at
one specific time point. However, at passage 10, cell spreading areas
were almost twice the size of that of cells at passage 4 on all substrates
(Fig. 5B). At this late passage, folds in the actin structure indicative of
membrane ruffles [61,62] were observed at the periphery of cells that
had been cultured on TPS and solid microcarriers. Actin stress fibres were
also poorly organised (Fig. 5A). Membrane ruffling is considered as an
indicator of inefficient lamellipodia adhesion and enhanced motility
[61–63]. Therefore, these observations may suggest a reduction in stable
Fig. 3. MSCs can be directly transferred from microdroplets, without enzymatic treatment. A) Schematic representation of direct transfer of cells from droplets to
other droplets or to solid substrates. B) Epifluorescence microscopy image of MSCs migrating from a confluent droplet to a recently prepared tagged (Alexa Fluor 594-
PLL) microdroplet (day 3 after introduction). Blue, nuclei; Red, PLL. C and D) Imaging of droplet to droplet (C) and droplet to solid (D) cell transfer (taken from
Supplementary Videos S1 and S2, respectively) indicating the migration of MSCs from microdroplets, during a time course of 18 h. Note the bulge developing at the
interface between two droplets (indicated by the arrow with *), the disappearance of cells from one of the droplets (indicated by the arrow with **) and the
appearance of cells spreading on the solid substrate (indicated by the arrow with ***), underlying cell transfer. Dashed lines indicate examples of the cell contours
indicated by the arrows.
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Fig. 4. MSC proliferation on TPS, bioemulsions and microcarriers at passage 4. A) Epifluorescence microscopy images of Hoechst stained MSCs cultured on TPS,
bioemulsions and microcarriers at days 1 and 5 of the first passage cycle (from passage 3 cells). B and C) Corresponding MSC densities quantified via CYQUANT™
assay. Error bars are S.E.; n  3.
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regarded as characteristics of senescent cells [60]. In the case of cell
circularity, no significant changes were observed at all time points, on all
substrates and MSCs maintained an elongated shape with circularities
near 0.23 (Fig. 5C).
To confirm observations made on cell spreading and morphologies,
the formation of matrix adhesion was investigated. The number of focal
adhesions (quantified from vinculin staining and microscopy), their area,
circularity, aspect ratio and size distribution were systematically quan-
tified (Supplementary Fig. S5). No significant difference was observed for
any of these parameters when comparing across different substrates or
time points (apart from the number of focal adhesions that was overall
increased at P10 compared to cells at P4). The increased number of ad-
hesions observed at late time points is in agreement with the overall
increased spreading area. The histograms of adhesion size distribution
(Supplementary Fig. S5E) revealed that the majority of adhesions were
typically smaller than 2 μm2 at early time points, but that the percentage
of adhesions below 1 μm2 increased from P4 (near 33%) to P10 (over
35%). Adhesion areas below 1 μm2 are typically identified as focal
complexes rather than focal adhesions [64,65]. Increased level of focal
complexes may therefore reflect increased cell spreading as well as a
potential increase in mobility at P10.
The expression of typical MSC surface markers, including CD105,
CD90 and CD73, was characterized next, via immuno-phenotyping flow
cytometry. MSCs gradually lost the co-expression of these three markers
at late passage times, with significantly reduced triple co-expression at
P10 compared to P4 (Fig. 6). However, no significant difference was
observed between substrates at any given time point. Analysis of each
marker individually, indicated that high CD73 expression was main-
tained on all substrates throughout the culture time, whereas the ex-
pressions of both CD90 and CD105 was reduced at later passages
(Supplementary Fig. S6). We noted some variation in the expression of8
these markers at P6 and P8, but below the threshold of statistical sig-
nificance, followed by a substantial decrease in expression at P10. The
downregulation of CD90 and CD105 has been proposed to be associated
with differentiation [66–71]. The downregulation of these markers is
therefore not unexpected, and correlates with the change in MSC adhe-
sion and morphology, as well as reduced proliferation, observed at later
culture times. It is also worth noting that MSCs have been reported to
display comparatively high autofluorescence, due to endogenous fluo-
rophores such as nicotinamide adenine dinucleotide (NADH), flavin
adenine dinucleotide (FAD) or structural proteins including COL and
elastin [72,73]. Increased cell sizes at later passages could therefore in-
crease autofluorescence, and may mask the signal of weakly expressed
surface markers (as gated against FMO controls). As shown in Fig. 6B, the
gating of MSCs that co-expressed CD90 and CD105 on bioemulsions and
microcarriers was generally higher than that of TPS, therefore potentially
contributing to the slight decrease in expression of these markers on
these substrates. However, in the histogram of population for each in-
dividual marker remained comparable (Supplementary Fig. S6). Overall,
MSCs on TPS displayed slightly reduced expression of CD90 and CD105
at passage 10 (compared to passage 4).
Considering the retention of stemness-associated surface markers
observed until P10 for MSCs cultured on TPS, bioemulsions and solid
microcarriers, the expression of stemness markers THY, NES and VCAM-1
was monitored next. At the gene expression level, few significant dif-
ferences were observed between cells cultured on the different substrates
throughout the culture time (Fig. 7). Interestingly, THY, also known as
CD90, which had displayed downregulated surface marker expression at
later passage in flow cytometry experiments, was found to be upregu-
lated at the gene expression level by RT-PCR, suggesting that such high
THY expression level does not translate into surface marker presentation,
within the time frame studied. In turn, the neural marker Nestin, reported
to be upregulated upon culture on soft substrates [74], remained
Fig. 5. Evolution of MSC spreading and morphology after culture on TPS, bioemulsions and solid microcarriers for 6 passages. A) Confocal microscopy images of MSCs
spreading on FN-coated glass slides for 24 h, following long term culture on corresponding substrates (green, vinculin; red, actin; blue, DAPI). Arrows indicate ex-
amples of poorly organise stress fibres at late passages for cells culture on TPS and microcarriers. Quantification of cell spreading area (B, unless indicated by a bar,
statistical comparisons refer to the same condition at P10) and circularity (C, “Circ”), calculated from the analysis of actin images. Error bars are S.E.; n  3, more than
40 cells for each condition were measured in each experiment. *, p < 0.05; **, p < 0.01; ***, p < 0.001 and n.s., non-significant.
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bioemulsions. VCAM-1, also known as CD106, is an adhesion molecule
that has been reported to mediate homing, migration and adhesion of
MSCs [75,76]. The expression of this molecule was also found to be
largely unaltered on the different substrates studied, at different passage
times. Overall, our data demonstrate that, despite the macroscopically
soft character of bioemulsions (and low viscosity of the oil selected for
this study), the mechanical strength of the protein nanosheets9
self-assembled is sufficient to sustain cell adhesion and retain a stem cell
phenotype, with little evidence for the loss of surface expression markers
or changes in the expression of stemness-associated genes, beyond their
variation as a function of passage time.
To confirm the retention of multi-potency of MSCs cultured on bio-
emulsions, MSC differentiation towards three lineages (adipogenic,
osteogenic and chondrogenic) was induced in corresponding differenti-
ation media. As the ECM biochemistry and mechanics are also able to
Fig. 6. MSC expression of surface markers at different time points, when cultured on TPS, bioemulsions and solid microcarriers. A) (Top) Bar chart of the percentage
of MSCs co-expressing CD73, CD90 and CD105, as a function of passage time and (Bottom) corresponding line chart. Error bars are S.E.; n  3. B) Representative
examples of dot plots of CD105 against CD90 expression, with positive gating indicated.
Fig. 7. MSCs retain comparable levels of expression of stemness-associated genes on TPS, bioemulsions and solid microcarriers over long-term culture. RNA was
directly extracted from MSCs cultured on TPS, bioemulsions and solid microcarriers at different passage times and reverse transcribed into cDNA for PCR experiments.
Results are shown as relative fold change of gene expressed by MSCs on different substrates relative to that of newly thawed MSCs on TPS. Error bars are S.E.; n  3.
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TPS, from the corresponding long term expansion substrates. Adipo-
genesis (examined from oil red staining of lipid droplets, Fig. 8A) was
clearly apparent with cells cultured on all three substrates, compared to
the control group cultured in growth medium. Differentiation towards
adipogenic lineages was also confirmed by RT-PCR, through the clear
upregulation of the adipogenesis marker genes FABP4 and LPL. No10statistically significant difference was found between expression of these
genes in cells cultured on the different substrates studied at the same
passage (Supplementary Fig. S7A). However, it was clear that MSCs
gradually lost their adipogenic potential on prolonged culture. Since
MSCs do not express FABP4 and LPL when culture in growthmedium, the
relative fold change of gene expression was normalised to P4 MSCs on
TPS in differentiation medium. The expression of FABP4 on MSCs
Fig. 8. MSCs retain a multipotent phenotype after long-term culture on TPS, bioemulsions and solid microcarriers. MSCs were harvested from different substrates and
subsequently cultured on TPS in differentiation media (14 days for adipogenic and osteogenic differentiation, 21 days for chondrogenesis). Bright field images of (A)
Oil Red staining, (B) ALP staining, (C) Alizarin Red staining and (D) Alcian Blue stainings of corresponding samples. Controls were MSCs of the same passage harvested
from TPS and cultured in growth medium (adipogenesis and osteogenesis) or DMEM (chondrogenesis).
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regulated at P8 compared to P4, however it was higher on TPS at P4.
Although FABP4 is an early indicator of adipogenesis, this reduction does
not necessarily imply that adipogenesis was halted as LPL expression at
the same passages remained comparable, consistent with Oil Red stain-
ings. Overall, such high expression levels compared to controls cultured
in expansion medium indicate the retention of adipogenic potential even
for MSCs cultured at P8 on the different substrates.
The induction of osteogenesis by MSCs has been identified as a multi-
step process. It is initiated with a proliferation stage until the establish-
ment of confluency, followed by a matrix maturation step, at which point
the expression of ALP and RUNX2 becomes detectable [77,78]. The
expression of RUNX2 indicates MSC commitment towards osteogenic
lineages, resulting in the activation of the expression of type I COL and
triggering matrix mineralisation, including OCN and osteopontin depo-
sition, as well as calcium deposition [79,80]. Early osteogenesis was
characterised by ALP staining. As shown in Fig. 8B, similar ALP activity
can be observed for cells cultured on all three substrates, even at late
passages, confirming their ability to differentiate into osteoblasts. Inter-
estingly, ALP activity was also observed in the control group at passage 8
in growth medium, which is consistent with previous findings [74]
showing that prolonged culture of MSCs on rigid substrates (TPS) induces
osteogenic differentiation. Matrix mineralisation through calcium
deposition was characterised via Alizarin Red staining (Fig. 8C).
Although calcium deposition was observed on all substrates, a clear
decrease occurs after prolonged culture (P8). However, trends in gene
expression were less clear (Supplementary Fig. S7B), with no significant
changes in the expression of RUNX2, BMP-2, COL1A1 and ALP, as a
function of substrate type or passage number. BMP-2 has been widely
studied and recognised as an important factor stimulating RUNX211expression [80,81], which subsequently activates COL1A1. Therefore,
the up-regulation of BMP2 expression and down-regulation of RUNX2
and COL1A1 expression at later passages may suggest that the osteo-
genesis process was slowing down at passage 8, although this was not
significant. The role of BMP-2 in regulating matrix mineralisation has
also been widely demonstrated [80]. COL1A1, ALP and RUNX2 expres-
sion was reported to decline upon initiation of matrix mineralisation
[82]. Thus RT-PCR results may reflect a complex balance of differential
regulation of matrix remodelling genes. In addition, although Alizarin
Red staining indicated a reduction in mineralisation at P8, ALP activity
was found to increase. These results are in agreement with the literature,
with reports suggesting that cell senescence may promote the osteogenic
differentiation [55,83,84], although others suggest the promotion of
adipogenic commitment at later passages [59,60]. It is worth noting that
in other reports, senescence impaired differentiation towards all lineages
[73]. In our study, ALP activity at P8 was similar to P4 whereas the
calcium deposition was reduced. Therefore, our results indicate that
osteogenesis slowed down at P8 (Fig. 8B and C). However, overall the
osteogenic potential of MSCs cultured on the three substrates studied was
comparable.
Finally, chondrogenesis was induced in spheroid cultures, and Alcian
Blue staining was performed to characterise the secretion of the cartilage
matrix proteoglycan aggrecan. The formation of spheroids was observed
in all conditions. Cells cultured in basal DMEM displayed lighter staining,
whilst cells cultured in differentiation medium showed a dark blue
staining indicative of abundant aggrecan deposition (Fig. 8D). The
secretion of aggrecan seemed lighter at later passages, indicating a
reduction in chondrogenic potential. Although no statistically significant
differences in the expression of chondrogenesis-associated genes SOX9,
COL2A1 and COL10A1 (between substrates and at P4 and P8), a gradual
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Fig. S7C). COL2A1, in particular, which plays an important role in the
regulation of the formation of articular cartilage was found to be more
sensitive to passage numbers [85]. In comparison, SOX9 is expressed by
proliferative chondrocytes in growth cartilage [86], and is reported to
induce the secretion of the major cartilage matrix components type II and
type X collagen, via the activation of the expression of COL2A1 and
COL10A1 genes [79,85,86]. However, despite its role in promoting
mineralisation of cartilage, COL10A1 is also associated with hypertro-
phic cartilage, which is undesirable for chondrogenesis at late stages [85,
87]. Since SOX9 is hardly expressed by hypertrophic chondrocytes [86],
the similar expression profile of SOX9 and COL10A1 in our experiments
suggests that chondrocytes remained in a growth stage over the whole
period of the experiments. Thus, the downregulation of COL10A1 in this
case is proposed to indicate a loss of chondrogenic potential, to compa-
rable level for the different substrates used in this study.
4. Conclusion
Therefore, our data demonstrate that bioemulsions stabilised by
protein nanosheets such as PLL that display both strong interfacial me-
chanics and allow tethering or adsorption of ECM proteins, and poten-
tially cell-adhesive ligands, enable the long term expansion of stem cells
such as MSCs and the retention of their multi-potent phenotype. Our
results demonstrate that the phenotype of MSCs cultured for up to the
equivalent of six passages (47 days) on bioemulsions is comparable to
that of MSCs cultured on solid microcarriers (and one of the current gold
standards in the field, Synthemax® II). Our data also indicate that there is
limited benefit of continuing to culture MSCs on 2D plastic as there is no
systematic quantitative evidence for the retention of improved multi-
potency with this culture system and it is particularly restrictive in terms
of scale up, automation and parallelisation. Indeed, although flow
cytometry analysis indicates a slightly higher retention of triple surface
marker co-expression for cells cultured on TPS (not statistically signifi-
cant), this does not correlate with an increase in stemness gene expres-
sion (THY, NES, VCAM-1). The retention of multipotency is also
comparable for MSCs cultured on bioemulsions and solid microcarriers
compared to those cultured on TPS and the expression of some of the
differentiation-associated genes is slightly upregulated on 3D micro-
carriers (in particular for adipo- and osteogenic differentiation). Cell
densities are also increased on 3D microcarriers compared to TPS.
We however note that further medium optimisation (including for
inducing differentiation) may highlight differences between the culture
systems compared in our study. Similarly, the selection of microdroplets
with homogenous and defined sizes might allow the identification of a
more restricted set of conditions enabling a better (prolonged) control of
MSC phenotype upon culture on bioemulsions. Other aspects requiring
further examination include the stability of emulsions upon storage,
transport and during long term expansion (although we note that the
increase in droplet size observed in our system did not correlate with an
altered phenotype, compared to cells cultured on homogenous micro-
particles), as well as optimisation of initial cell seeding and cell transfer
between droplets.
Although the ability to culture and retain high proliferation levels at
the surface of microdroplets may seem surprising, considering the
importance of substrate mechanics on cell adhesion, spreading and
phenotype, we note that the interfacial mechanical properties of protein
nanosheets, in particular PLL nanosheets, are relatively stiff, at the local
scale [47,48,88]. We propose that the dimensions of corresponding
nanosheets (with thicknesses in the range of 10–20 nm, based on AFM
data [48]) and their moduli (extrapolated to Young's moduli in the range
of 1–100 MPa, based on interfacial rheology data [48,88]) are sufficient
to resist forces generated by contractile and adhesive structures dis-
playing comparable dimensions and stiffnesses (the acto-myosin net-
works and focal adhesion plaques; typically a few tens of nm across and
with stiffnesses more difficult to directly quantify but unlikely to be in the12GPa range).
These results also indicate that the use of mild enzymatic dissociation
conditions for the resuspension of cells during passaging (such as Accu-
tase) is not detrimental to MSC phenotype and that this process is mainly
restrictive from a scale up and automation point of view rather than an
intrinsic limiting parameter altering cell phenotype. These results
contradict previous reports that proposed that enzymatic digestion is
intrinsically harmful to cells and results in a loss of cell phenotypes
[89–91]. Although this may be cell type dependent and enzymatic
damage may be more evident with trypsin treatment, our data indicate
that Accutase treatment is not significantly impairing the retention of
MSC phenotype. However, enzymatic digestion and cell detachment, if
not optimised, remains prone to error and increases risks of contamina-
tions or cell/phenotype loss (i.e. if cells are not reseeded fast enough or if
digestion is too long) and next generation cell manufacturing platforms
should certainly focus on bypassing it. Overall, our results demonstrate
that bioemulsions are a promising new generation of microcarriers for
the long-term culture of adherent stem cells, including MSCs. In addition,
bioemulsions offer significant advantages in terms of processing and
scale up of cell culture and manufacturing, including significant cost
reduction (the cost of the bioemulsions used in the present study was>10
fold lower than the cost of the microcarriers used). Indeed, cells can be
recovered very readily via centrifugation (and potentially filtration or
direct delivery of cell-laden oil droplets) and the oil phase contributes to
the limitation of the use of microplastics in healthcare technologies, and
could potentially be recycled after filtration. Finally, many oils, including
fluorinated oils such as Novec 7500, but most importantly mineral and
vegetal oils, remain considerably more affordable than currently used
solid microcarriers (by a factor of at least 10 fold). Overall, bioemulsions
constitute a unique opportunity to rethink the cell manufacturing pipe-
line and the processes associated with cell handling, recovery and
post-culture processing for applications in tissue engineering, regenera-
tive medicine, biotherapeutics production or synthetic meat production.
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